By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Castle Biosciences 



Houston  Texas    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Diagnostics






Company News
Study Shows Castle Biosciences’ Gene Expression Profile Test Successfully Identified High Risk Disease In A Cohort Of 217 Melanoma Patients Who Underwent Sentinel Lymph Node Biopsy 6/2/2014 12:49:56 PM
Castle Biosciences' Esophageal Cancer Test Accurately Predicts Pre-Surgical Treatment Response 6/2/2014 9:13:13 AM
Castle Biosciences' Melanoma Gene Expression Profile Test To Be Subject Of Presentation At American Society of Clinical Oncology Annual Meeting 5/15/2014 6:43:25 AM
Castle Biosciences' Esophageal Cancer Test Identifies Patients Who Are Resistant To Standard Pre-Surgical Chemoradiation Therapy 5/6/2014 9:42:02 AM
Castle Biosciences' Mesothelioma Molecular Test Accurately Stratifies Survival Risk Under Surgical And Non-Surgical Treatment Plans 4/29/2014 10:54:36 AM
Castle Biosciences Announces Data Demonstrating Ability To Identify Esophageal Cancer Patients Resistant To Standard Pre-Surgical Treatment Of Chemotherapy And Radiation 1/16/2014 10:20:58 AM
Castle Biosciences Launches Tissue Repository for Eye Cancer Patients 9/30/2013 9:39:21 AM
Castle Biosciences Genetic Test Highly Accurate in Differentiating Thymomas From Thymic Carcinoma Tumors 9/25/2013 10:31:20 AM
Castle Biosciences Release: Gene Test Identifies Non-Metastatic Melanoma Patients at High Risk of Recurrence 8/5/2013 9:43:31 AM
Castle Biosciences Release: New Website Dedicated to Patients With Thymic Cancer 7/30/2013 7:44:52 AM
12
//-->